Papers published in national and international conferences or symposium proceedings (20)
  1. 15. Leroy, K., Ando, K., Laporte, V., Dedecker, R., Suain, V., Authelet, M., Heraud, C., Pierrot, N., Yilmaz, Z., Octave, J. N., & Brion, J. P. (2012). Tau deletion rescues neuronal death in APP/PS1 mice. In Alzheimer's & Dementia: The journal of the Alzheimer's association: Vol. 8 (4 ed., p. 87) Elsevier.
  2. 16. Brion, J. P., Ando, K., Heraud, C., Leroy, K., & Morel, M. (2011). Tau and GSK3beta. Alzheimer's & Dementia: The journal of the Alzheimer's association. Vol. 7 (4 ed., p. 676) AAIC 2011(2011-07-16 to 2011-07-21: Paris).
  3. 17. Brion, J. P., Leroy, K., Ando, K., Bretteville, A., Yilmaz, Z., Authelet, M., Dedecker, R., & Buée, L. (2008). Subacute per OS lithium treatment decreases Tau phosphorylation and neurofibrillary tangles load in G272V/P301S mutant Tau transgenic mice. Alzheimer's & Dementia: The Journal of Alzheimer's Association. Vol. 4 (4 ed., p. 185) ICAD 2008(2008-07-26 to 2008-07-31: Chicago, USA).
  4. 18. Galas, M.-C., Dourlen, P., Ando, K., Bégard, S., Hamdane, M., & Buée, L. (2008). Pin1 deregulation in Alzheimer's disease: A role in the aberrant cell cycle re-entry? Alzheimer's & Dementia: The Journal of the Alzheimer's Association. Vol. 4 (4 ed., p. 613) ICAD 2008(2008-07-26 to 2008-07-31: Chicago, USA).
  5. 19. Galas, M.-C., Dourlen, P., Bégard, S., Ando, K., Hamdane, M., & Buée, L. (2006). Pin1 modulates oxidative stress-induced dephosphorylation of tau in neurons: Implication of the peptidyl prolyl cis/trans isomerase in a pathological mechanism related to Alzheimer’s disease. In Alzheimer's & Dementia: The Journal of the Alzheimer's Association: Vol. 2 (3 ed., p. 473) Elsevier.
  6. 20. Ando, K., Bunai, F., Ueno, H., & Numata, O. (2002). TETRAHYMENA ELONGATION FACTOR-1α (EF-1α) BUNDLES FILAMENTOUS ACTIN BY FORMING A DIMER: A NOVEL EVIDENCE OF THE EF-1α DIMER MODEL (Cell Biology and Morphology)(Proceedings of the Seventy-Third Annual Meeting of the Zoological Society of Japan). Zoological science. Vol. 19 (12 ed., p. 1432) the Seventy-Third Annual Meeting of the Zoological Society of Japan(73: 2002-03-30: Tokyo, Japan).
    7.   Research reports, book reviews, letters to the editor, working papers (1)
  7. 1. Ando, K., Ferlini, L., Suain, V., Yilmaz, Z., Mansour, S., Le Ber, I., Bouchard, C., Leroy, K., Durr, A., Clot, F., Sarazin, M., & Bier, J. C. (2020). De novo MAPT mutation G335A causes severe brain atrophy, 3R and 4R PHF-tau pathology and early onset frontotemporal dementia. Acta neuropathologica communications, 8(1), 94. doi:10.1186/s40478-020-00977-8
    8.   Active participation in international conferences and symposiums (57)
  8. 1. De Fisenne, M.-A., Yilmaz, Z., De Decker, R., Suain, V., Mansour, S., Buée, L., Ando, K., Brion, J. P., & Leroy, K. (2022). Alzheimer PHF-tau do not spread tau pathology to the brain via the retinotectal pathway after intraocular injection in mouse models. Paper session presented at International conference on Alzheimer and Parkinson's diseases (15-22 March 2022: Barcelona).
  9. 2. De Fisenne, M.-A., Houben, S., Ando, K., Vanden Dries, V., Poncelet, L., Yilmaz, Z., Mansour, S., De Decker, R., Brion, J. P., & Leroy, K. (2022). Intravenous injection of PHF-Tau proteins from Alzheimer Brain exacerbates neuroinflammation, Amyloid beta, and tau pathologies in 5XFAD transgenic mice.. Vol. 145 (p. 411) Abstract session presented at International conference on Alzheimer and Parkinson's diseases(15-20 Mars 2022: Barcelona).
  10. 3. De Fisenne, M.-A., Yilmaz, Z., De Decker, R., Suain, V., Mansour, S., Buée, L., Ando, K., Brion, J. P., & Leroy, K. (2022). Alzheimer PHF-tau do not spread tau pathology to the brain via the retinotectal pathway after intraocular injection in mouse models.. Vol. 130 (p. 176) Abstract session presented at International conference on Alzheimer and Parkinson’s diseases(15-22 mars 2022: Barcelona).
  11. 4. De Fisenne, M.-A., Yilmaz, Z., De Decker, R., Suain, V., Mansour, S., Buée, L., Ando, K., Brion, J. P., & Leroy, K. (2021). Alzheimer PHF-tau do not spread tau pathology to the brain via the retinotectal pathway after intraocular injection in mouse models. (p. 54) Abstract session presented at Oral presentation to the Third Eurotau meeting(October 25-26,: Lille, France).
  12. 5. Doeraene, E., Erneux, C., Yilmaz, Z., Mansour, S., Suain, V., Turbant, S., Duyckaerts, C., Brain Bank NeuroCEB Neuropathology Network,, Schurmans, S., Brion, J. P., Leroy, K., & Ando, K. (2021). Protein level and solubility of the PI 5-phosphatase SHIP2 is altered in correlation with amyloid pathology in Alzheimer’s brains. (p. 102) Abstract session presented at New Horizons in Alzheimer’s Disease(October 27-28, 2021: Leuven, Belgium).
    13. << Previous 1 2 3 4 5 6 7 8 9 10 11 Next >>